In: The insights you need from Harvard Business Review
Section 1. Understanding blockchain: The truth about blockchain: it will take years to transform business, but the journey begins now / Marco Iansiti and Karim R. Lakhani -- A brief history of blockchain: it's come a long way in 10 years / Vinay Gupta -- The blockchain will do to the financial system what the internet did to media: what we can learn from the evolution of another groundbreaking technology / Joichi Ito, Neha Narula, Robleh Ali -- Who controls the blockchain: no one, and everyone, by design / Patrick Murck -- How safe are blockchains? it depends: the security issues are different in public and private networks / Allison Berke -- What blockchain can't do: someone needs to verify the link between digital records and physical objects / Catherine Tucker and Christian Catalani -- Section 2. Blockchain and business: How blockchain is changing finance: it could reduce friction and costs / Alex Tapscott and Don Tapscott -- As cryptocurrencies rise, who needs banks?: it's a tough time to be a middleman / Antonio Fatás and Beatrice Weder di Mauro -- The hidden costs of initial coin offerings: ICOs are often at odds with how risky ventures are usually funded / Jeffrey Bussgang and Ramana Nanda -- Global supply chains are about to get better, thanks to blockchain: we'll be able to track goods between companies and across borders / Michael J. Casey and Pindar Wong -- What blockchain means for the sharing economy: the role of platforms will become less important / Primavera De Filippi -- How blockchain can help marketers build better relationships with their customers: for one, the technology can cut down on spam and fraud / Campbell R. Harvey, Christine Moorman, and Marc Toledo -- Blockchain could help artists profit more from their creative works: movie studios and record companies should take note / Don Tapscott and Alex Tapscott -- Section 3. The future of blockchain: Does your idea actually require blockchain?: what Chinese #MeToo activism teaches us about data integrity / Catherine Tucker and Yudan Pang -- How regulation could help cryptocurrencies grow: entrepreneurs sit on the sidelines for fear of innocently running afoul of the law / Stephen J. Obie and Mark W. Rasmussen -- Using blockchain to keep public data public: information is under attack / Brian Forde -- Blockchain will help us prove our identities in a digital world: and the benefits will accrue to all rungs of society / Michael Mainelli -- Making cryptocurrency more environmentally sustainable: in one year, blockchain activity used more power than 159 individual nations / Marc Blinder.
Cardiovascular diseases are leading causes of death, globally, and health systems that deliver quality clinical care are needed to manage an increasing number of people with risk factors for these diseases. Indicators of preparedness of countries to manage cardiovascular disease risk factors (CVDRFs) are regularly collected by ministries of health and global health agencies. We aimed to assess whether these indicators are associated with patient receipt of quality clinical care. We did a secondary analysis of cross-sectional, nationally representative, individual-patient data from 187,552 people with hypertension (mean age 48.1 years, 53.5% female) living in 43 low- and middle-income countries (LMICs) and 40,795 people with diabetes (mean age 52.2 years, 57.7% female) living in 28 LMICs on progress through cascades of care (condition diagnosed, treated, or controlled) for diabetes or hypertension, to indicate outcomes of provision of quality clinical care. Data were extracted from national-level World Health Organization (WHO) Stepwise Approach to Surveillance (STEPS), or other similar household surveys, conducted between July 2005 and November 2016. We used mixed-effects logistic regression to estimate associations between each quality clinical care outcome and indicators of country development (gross domestic product [GDP] per capita or Human Development Index [HDI]); national capacity for the prevention and control of noncommunicable diseases ('NCD readiness indicators' from surveys done by WHO); health system finance (domestic government expenditure on health [as percentage of GDP], private, and out-of-pocket expenditure on health [both as percentage of current]); and health service readiness (number of physicians, nurses, or hospital beds per 1,000 people) and performance (neonatal mortality rate). All models were adjusted for individual-level predictors including age, sex, and education. In an exploratory analysis, we tested whether national-level data on facility preparedness for diabetes were positively ...
Preliminary Material /Jessica Aliaga Lavrijsen and Michael Bick -- The Psychotherapy of Victims and Perpetrators of Domestic Violence as a Treatment of Trauma Experienced in Childhood /Dorota Dyjakon and Agnieszka Widera-Wysoczańska -- Childhood Abuse in Memoir: Blaming and Forgiving Mentally Ill Abusers /Christian Perring -- 'Pinpricks of Light That Broke My Heart:' Sexual Violence, Trauma and Sadomasochism in Mary Gaitskill's Two Girls, Fat and Thin (1991) /Emily Dickinson -- Reading for the Body: Reinforcing Somatic Reality in the Study of Trauma /Wilfred Bradford -- Re-Living Motherhood: Vocalising Grief, Trauma and Loss in Butler's Lilith's Brood /Aparajita Nanda -- Early Relational Trauma, Massive Psychic Trauma and Their Intergenerational Transmission /Clara Mucci -- Intergenerational Transmission of Trauma: The Case of the Dersim Massacre 1937-38 /Filiz Çelik -- The Trauma behind the Myth: The Necessity to Recover the Past in Gloria Naylor's Mama Day /Patricia San José Rico -- Female Scottish Trauma in Janice Galloway's The Trick Is to Keep Breathing (1989) /Jessica Aliaga Lavrijsen -- Poetry of Witness: Marjorie Agosín's Response to the Trauma of the Disappeared in Pinochet's Chile /Catherine Ann Collins -- Ruin Nation: Constructing Identity in The Pagoda /Michael Bick -- Wounds and History: Post-Colonial Trauma in José Eduardo Agualusa's The Book of Chameleons /Bálint Urbán -- Trauma in Postcolonial Bildungsromane as Reflected in Selected Novels /Hano Pipic -- Post-War Trauma: 'A Game of Chess' in T. S. Eliot's The Waste Land /Ömer Ögünç -- The Aesthetics of Hopelessness After the Holocaust in Eva Figes' Konek Landing /Silvia Pellicer-Ortín -- The Art of Trauma: Holocaust Restatement in the Graphic Novel /Chanae Bazemore -- Remembering Israel's Longest War: Filming the Lebanese Quagmire /Jeanne Ellen Clark -- Trauma and the Vampire: The Violence of the Inescapable Moment in Let Me In (2010) by Matt Reeves /Simon Bacon -- The Trauma of the Colonised: Writing Female in Barbara Baynton's Human Toll /Bridget Haylock -- Trauma and Art in the Contemporary South African Novel: Susan Mann's Quarter Tones /Ewald Mengel -- Post-Traumatic Responses in the War Narratives of Hanan al-Shaykh's The Story of Zahra and Chimamanda Ngozi Adichie's Half of a Yellow Sun /Majda R. Atieh and Ghada Mohammad -- Sandplay Therapy for the Healing of Trauma /Evgenia Troshikhina -- Recovery in Rwanda: The Traditional Courts for Reconciliation /Moara Crivelente -- 'Why Can't I Stop Looking?' A Therapeutic and Performative Debate on the Performance of Trauma /Oliver Bray and Peter Bray -- Shock of the Real versus Shocking Realities: Critical Theory and the Normalisation of Trauma /Ulrich Koch.
Verfügbarkeit an Ihrem Standort wird überprüft
Dieses Buch ist auch in Ihrer Bibliothek verfügbar:
Declines in health service use during the Coronavirus Disease 2019 (COVID-19) pandemic could have important effects on population health. In this study, we used an interrupted time series design to assess the immediate effect of the pandemic on 31 health services in two low-income (Ethiopia and Haiti), six middle-income (Ghana, Lao People's Democratic Republic, Mexico, Nepal, South Africa and Thailand) and high-income (Chile and South Korea) countries. Despite efforts to maintain health services, disruptions of varying magnitude and duration were found in every country, with no clear patterns by country income group or pandemic intensity. Disruptions in health services often preceded COVID-19 waves. Cancer screenings, TB screening and detection and HIV testing were most affected (26–96% declines). Total outpatient visits declined by 9–40% at national levels and remained lower than predicted by the end of 2020. Maternal health services were disrupted in approximately half of the countries, with declines ranging from 5% to 33%. Child vaccinations were disrupted for shorter periods, but we estimate that catch-up campaigns might not have reached all children missed. By contrast, provision of antiretrovirals for HIV was not affected. By the end of 2020, substantial disruptions remained in half of the countries. Preliminary data for 2021 indicate that disruptions likely persisted. Although a portion of the declines observed might result from decreased needs during lockdowns (from fewer infectious illnesses or injuries), a larger share likely reflects a shortfall of health system resilience. Countries must plan to compensate for missed healthcare during the current pandemic and invest in strategies for better health system resilience for future emergencies.
In: Yoshida , S , Martines , J , Lawn , J E , Wall , S , Souza , J P , Rudan , I , Cousens , S , Aaby , P , Adam , I , Adhikari , R K , Ambalavanan , N , Arifeen , S E , Aryal , D R , Asiruddin , S , Baqui , A , Barros , A J , Benn , C S , Bhandari , V , Bhatnagar , S , Bhattacharya , S , Bhutta , Z A , Black , R E , Blencowe , H , Bose , C , Brown , J , Bührer , C , Carlo , W , Cecatti , J G , Cheung , P-Y , Clark , R , Colbourn , T , Conde-Agudelo , A , Corbett , E , Czeizel , A E , Das , A , Day , L T , Deal , C , Deorari , A , Dilmen , U , English , M , Engmann , C , Esamai , F , Fall , C , Ferriero , D M , Gisore , P , Hazir , T , Higgins , R D , Homer , C S , Hoque , D E , Irgens , L & neonatal health research priority setting group 2016 , ' Setting research priorities to improve global newborn health and prevent stillbirths by 2025 ' , Journal of Global Health , vol. 6 , no. 1 , pp. 010508 . https://doi.org/10.7189/jogh.06.010508
BACKGROUND: In 2013, an estimated 2.8 million newborns died and 2.7 million were stillborn. A much greater number suffer from long term impairment associated with preterm birth, intrauterine growth restriction, congenital anomalies, and perinatal or infectious causes. With the approaching deadline for the achievement of the Millennium Development Goals (MDGs) in 2015, there was a need to set the new research priorities on newborns and stillbirth with a focus not only on survival but also on health, growth and development. We therefore carried out a systematic exercise to set newborn health research priorities for 2013-2025. METHODS: We used adapted Child Health and Nutrition Research Initiative (CHNRI) methods for this prioritization exercise. We identified and approached the 200 most productive researchers and 400 program experts, and 132 of them submitted research questions online. These were collated into a set of 205 research questions, sent for scoring to the 600 identified experts, and were assessed and scored by 91 experts. RESULTS: Nine out of top ten identified priorities were in the domain of research on improving delivery of known interventions, with simplified neonatal resuscitation program and clinical algorithms and improved skills of community health workers leading the list. The top 10 priorities in the domain of development were led by ideas on improved Kangaroo Mother Care at community level, how to improve the accuracy of diagnosis by community health workers, and perinatal audits. The 10 leading priorities for discovery research focused on stable surfactant with novel modes of administration for preterm babies, ability to diagnose fetal distress and novel tocolytic agents to delay or stop preterm labour. CONCLUSION: These findings will assist both donors and researchers in supporting and conducting research to close the knowledge gaps for reducing neonatal mortality, morbidity and long term impairment. WHO, SNL and other partners will work to generate interest among key national stakeholders, governments, NGOs, and research institutes in these priorities, while encouraging research funders to support them. We will track research funding, relevant requests for proposals and trial registers to monitor if the priorities identified by this exercise are being addressed.
In 2013, an estimated 2.8 million newborns died and 2.7 million were stillborn. A much greater number suffer from long term impairment associated with preterm birth, intrauterine growth restriction, congenital anomalies, and perinatal or infectious causes. With the approaching deadline for the achievement of the Millennium Development Goals (MDGs) in 2015, there was a need to set the new research priorities on newborns and stillbirth with a focus not only on survival but also on health, growth and development. We therefore carried out a systematic exercise to set newborn health research priorities for 2013-2025.We used adapted Child Health and Nutrition Research Initiative (CHNRI) methods for this prioritization exercise. We identified and approached the 200 most productive researchers and 400 program experts, and 132 of them submitted research questions online. These were collated into a set of 205 research questions, sent for scoring to the 600 identified experts, and were assessed and scored by 91 experts.Nine out of top ten identified priorities were in the domain of research on improving delivery of known interventions, with simplified neonatal resuscitation program and clinical algorithms and improved skills of community health workers leading the list. The top 10 priorities in the domain of development were led by ideas on improved Kangaroo Mother Care at community level, how to improve the accuracy of diagnosis by community health workers, and perinatal audits. The 10 leading priorities for discovery research focused on stable surfactant with novel modes of administration for preterm babies, ability to diagnose fetal distress and novel tocolytic agents to delay or stop preterm labour.These findings will assist both donors and researchers in supporting and conducting research to close the knowledge gaps for reducing neonatal mortality, morbidity and long term impairment. WHO, SNL and other partners will work to generate interest among key national stakeholders, governments, NGOs, and research institutes in these priorities, while encouraging research funders to support them. We will track research funding, relevant requests for proposals and trial registers to monitor if the priorities identified by this exercise are being addressed.
Antifungal Drugs from Endophytic Microbes: Present and Future Prospects / Rajreepa Talukdar, Sushmita Paul, and Kumananda Tayung -- Bioactive Compounds and Herbal Therapy for Alzheimer's Disease / Jayashree Prusty, and Srikanta Jena -- Wild Cucurbits: An Ethnomedicinally Important Plant Species for Aboriginals of the Similipal Biosphere Reserve, Odisha, India / Yasaswinee Rout, Sanjeet Kumar, Gitishree Das, and Jayanta Kumar Patra -- The Miracle Plant--Moringa / Karabi Biswas and Sankar Narayan Sinha -- Biomedical Application of Polymeric Biomaterial: Polyhydroxybutyrate / S. Mohapatra, D. Mohanty, S. Mohapatra, S. Sharma, S. Dikshit,I. Kohli, and D.P. Samantaray -- Thermostable Cyclodextrin Glycosyltransferase (CGTase): Recent Advances in Pharmaceutical Application of Cyclodextrins and Its Enzymatic Production / Amrita Swain, Luna Samanta, and Dhananjay Soren -- Mangrove Plants in Therapeutic Management of Diabetes: An Update / Swagat Kumar Das, Dibyajyoti Samantaray, and Swatismita Behera -- Microalgae as a Viable Bioresource for Sustainable Biofuel Production Through Biorefinery Technologies / Bunushree Behera, Suman Nayak, S. Rangabhashiyam, R. Jayabalan, and P. Balasubramanian -- Fruit Peel Waste "Biorefinery" and Sustainability Issues / Pranav D. Pathak, Saurabh N. Joglekar, Sachin A. Mandavgane, and Bhaskar D. Kulkarni -- Utilization of Bioresources: Toward Biomass Valorization for Biofuels / Samuel Eshorame Sanni, Oluranti Agboola, Emetere Moses, Emeka Okoro, Sam Sunday Adefila, Rotimi Sadiku, and Peter Alaba -- Lignocellulosic Waste-Derived Bioethanol as a Potential Biofuel for the Transportation Sector: Sources and Technological Advancement / Shitarashmi Sahu, Krishna Pramanik, and Neelam Meher -- Cost-Effective Production of Biofuels from Lignocellulosic Biomass: Prospects and Challenges / K.C. Samal and Laxmipreeya Behera -- Monitoring Innovations in Biofuel Production from Lignocellulosic Biomass: A Patent-based Approach / Suruchee Samparna Mishra, Sonali Mohapatra, and Hrudayanath Thatoi -- Effective Utilization of Palm Mesocarpic Husk: An Agrowaste in Producing Major Phenolics and Other Chemicals / Swapan Kumar Ghosh, and Kingsuk Das -- CRISPR/Cas9: An Invention for Plant Breeding and Agricultural Sustainability / Debashrita Mittra and Sabuj Sahoo -- Self-sustained Ramie Cultivation in Tripura: A Source of Multiple Commercial Uses for Adoption as an Alternative Livelihood / Shaon Ray Chaudhuri, Basant Kumar Agarwala, Sunil K. Sett, Priyasankar Chaudhuri, Piyali Paul, Gourav Bhattacharjee, Sumona Deb, Sukanya Chowdhury, Purnasree Devi, Sinchini Barman, Mandakini Gogoi, Tethi Biswas, Purabi Baidya, Abhispa Bora, Amrita Chakraborty, Chaitali Chanda, Saurav Saha, Ajoy Modak, Gautam Das, Priya Sarkar, Ronald Jamatia, Amitava Mukherjee, Ashutosh Kumar, Ashoke Ranjan Thakur, Mathumal Sudarshan, Rajib Nath, Leena Mishra, Indranil Mukherjee, Gautam Bose, Amarpreet Singh, and Ranjan Kumar Naik -- Azolla: A Viable Resource of Biofertilizer and Livestock Feed for Sustainable Development of Farming Community / Upendra Kumar, Snehasini Rout, Megha Kaviraj, Swastika Kundu, Hari Narayan, Himani Priya, and A.K. Nayak -- Bioremediation of Arsenic-Contaminated Environment Using Bacteria: An Update / Ranjan Kumar Mohapatra, Ritesh Pattanaik, Birendra Kumar Bindhani, Hrudayanath Thatoi, Pankaj Kumar Parhi -- Potential Applications of Coal Fly Ash: A Focus on Its Fungistatic Properties and Zeolite Synthesis / Sangeeta Raut -- Heavy Metal Toxicity and Their Bioremediation Using Microbes, Plants, and Nanobiomaterials / S.K. Sahu and H.G. Behuria -- Spent Coffee Waste Conversion to Value-Added Products for the Pharmaceutical and Horticulture Industry / Priya Sarkar, Tethi Biswas, Chaitali Chanda, Amrita Saha, Mathumal Sudarshan, Chanchal Majumder, and Shaon Ray Chaudhuri -- Bioremediation: An Ecofriendly Technology for Sustainable Aquaculture / S.K. Nayak and P.K. Nanda -- Biochar: An Advanced Remedy for Environmental Management and Water Treatment / Chinmayee Acharya, Aneeya K. Samantara, Abhisek Sasmal, Chittaranjan Panda, and Hrudayanath Thatoi.
Verfügbarkeit an Ihrem Standort wird überprüft
Dieses Buch ist auch in Ihrer Bibliothek verfügbar:
Background: The COVID-19 pandemic has disrupted routine hospital services globally. This study estimated the total number of adult elective operations that would be cancelled worldwide during the 12 weeks of peak disruption due to COVID-19. Methods: A global expert response study was conducted to elicit projections for the proportion of elective surgery that would be cancelled or postponed during the 12 weeks of peak disruption. A Bayesian β-regression model was used to estimate 12-week cancellation rates for 190 countries. Elective surgical case-mix data, stratified by specialty and indication (surgery for cancer versus benign disease), were determined. This case mix was applied to country-level surgical volumes. The 12-week cancellation rates were then applied to these figures to calculate the total number of cancelled operations. Results: The best estimate was that 28 404 603 operations would be cancelled or postponed during the peak 12 weeks of disruption due to COVID-19 (2 367 050 operations per week). Most would be operations for benign disease (90·2 per cent, 25 638 922 of 28 404 603). The overall 12-week cancellation rate would be 72·3 per cent. Globally, 81·7 per cent of operations for benign conditions (25 638 922 of 31 378 062), 37·7 per cent of cancer operations (2 324 070 of 6 162 311) and 25·4 per cent of elective caesarean sections (441 611 of 1 735 483) would be cancelled or postponed. If countries increased their normal surgical volume by 20 per cent after the pandemic, it would take a median of 45 weeks to clear the backlog of operations resulting from COVID-19 disruption. Conclusion: A very large number of operations will be cancelled or postponed owing to disruption caused by COVID-19. Governments should mitigate against this major burden on patients by developing recovery plans and implementing strategies to restore surgical activity safely.
The issue of the regulation of artificial intelligence (AI) is one of the significant challenges faced by the EU at present. Most researchers focus on the substantive scope of AI regulation, including state law, ethical norms and soft law. In addition to the substantive and legal scope of the regulation, it is worthwhile considering the manner of such regulation.1 Since AI is an algorithmic code, it seems correct to regulate (restrict) AI not so much with traditional law established in natural (human) language as with one implemented into algorithms. They may operate as a tool supporting traditional legislation (RegTech), but it is possible to go further with the issue and create regulation algorithms which implement the law as the effective law. However, this requires a new approach to law and legislation – the law as algorithmic code. ; University of Silesia, Poland ; Dariusz Szostek is Associate Professor in the Department of Civil Law and Civil Procedure at the Faculty of Law and Administration, Opole University, Poland, Head of the Centre for Legal Problems of Technical Issues and New Technologies; European Parliament AI Observatory science expert (2020–2024), and member of European Union Intellectual Property Office, Chairman of the Scientific Council of the Virtual Department of Law and Ethics. ; dariusz.szostek@szostek-bar.pl ; 43 ; 60 ; 3 ; Aires J., Pinheiro D., Strube de Lima V. and Meneguzzi F., Norm conflict identification in contracts, "Artificial Intelligence and Law" 2017, vol. 25. ; Araszkiewicz M.: Algorytmizacja myślenia prawniczego. Modele, możliwości, ograniczenia, (in:) D. Szostek (ed.), Legal tech. Czyli jak bezpiecznie korzystać z narzędzi informatycznych w organizacji, w tym w kancelarii oraz dziale prawnym, Warsaw 2021. ; Artificial Intelligence (AI): new developments and innovations applied to e-commerce, https://www.europarl.europa.eu/thinktank/en/document.html?reference=IPOL_IDA(2020)648791. ; Artificial Intelligence and Data Protection in Tension, 01.11.2018, https://www.informationpolicycentre.com/uploads/5/7/1/0/57104281/cipl_ai_first_report__artificial_intelligence_and_data_protection_in_te.pdf. ; Australian Government, Artificial Intelligence: Solving problems, growing the economy and improving our quality of life, 20.12.2019, https://data61.csiro.au/en/Our-Research/Our-Work/ AI-Roadmap. ; Badiul Islam M. and Governatori G., RuleRS: A Rule-Based Architecture for Decision Support Systems, "Artificial Intelligence and Law" 2018, vol. 26. ; Barfield W. and Pagallo U., Law and AI, Cheltenham/Northampton 2020. ; Barton T.D., Haapio H., Passera S. and Hazard J.G., Successful Contracts: Integrating Design and Technology, (in:) M. Corrales, M. Fenwick and N. Forgó (eds.), Robotics, AI and the Future of Law, Singapore 2018. ; Boulet R., Mazzega P. and Bourcier D., Network Approach to the French System of Legal Codes, part II: The Role of the Weights in a Network, "Artificial Intelligence and Law" 2018, vol. 26. ; Chinen M., Law and Autonomous Machines, Cheltenham 2019. ; Communication from the Commission to the European Parliament, the European Council, the Council, the European Economic and Social Committee and the Committee of the Regions on Artificial Intelligence for Europe, Brussels (COM(2018) 237), 25.04.2018, https://eur-lex.europa.eu/legalcontent/EN/TXT/?uri=COM% 3A2018%3A237%3AFIN. ; Corrales M., Fenwick M. and Haapio H., Legal Tech, Smart Contracts and Blockchain, Singapore 2019. ; Cyrul W., LegalTech a tworzenie i publikacja tekstów prawnych, (in:) D. Szostek (ed.), Legal Tech. Czyli jak bezpiecznie korzystać z narzędzi informatycznych w organizacji, w tym w kancelarii oraz dziale prawnym, Warsaw 2021. ; Declaration by the Committee of Ministers on the manipulative capabilities of algorithmic processes, 13.02.2019. ; eIDAS Regulation, https://digital-strategy.ec.europa.eu/en/policies/eidas-regulation. ; EU guidelines on ethics in artificial intelligence: Context and implementation, https://www.europarl.europa.eu/RegData/etudes/BRIE/2019/640163/EPRS_BRI(2019)640163_EN.pdf. ; European Artificial Intelligence (AI) leadership, the path for an integrated vision https://nws.eurocities.eu/MediaShell/media/European_AI_study.pdf. ; European Commission For The Efficiency Of Justice, European Ethical Charter on the use of artificial intelligence in judicial systems, Guidelines on Artificial Intelligence and Data Protection T-PD(2019)01, 14.04.2021. ; Executive Office of the President of the United States, 2016–2019 Progress report: Advancing artificial intelligence R&D (November 2019), https://www.whitehouse.gov/wp-content/ uploads/2019/11/AI-Research-and-Development-Progress-Report-2016–2019.pdf. ; Feldstein S., The Global Expansion and AI Surveillance, Washington 2019. ; Fenwick M., Vermeulen E.P.M. and Corrales M., Business and Regulatory Responses to Artificial Intelligence: Dynamic Regulation, Innovation Ecosystems and the Strategic Management of Disruptive Technology, (in:) M. Corrales, M. Fenwick and Nikolaus Forgó (eds.), Robotics, AI and the Future of Law, Singapore 2018. ; Finlay S., Artificial Intelligence and Machine Learning for Business, Great Britain 2018. ; Gautrais V., Lex Electronica: d'aujourd'hiu a demain, "Lex Electronica" 2016, http://www.lex-electronica.org/articles/volume-21/lex-electronica-daujourdhui-a-demain. ; Governatori G., Idelberger F., Milosevic Z., Riveret R., Sartor G. and Xu X., On legal contracts, imperative and declarative smart contracts, and blockchain system, "Artificial Intelligence and Law" 2018, vol. 26. ; Harasimiuk D. E. and Braun T., Regulating Artificial Intelligence. Binary Ethics and the law, London/ New York 2021. ; Hartung M., Bues M. and Halblieb G., Legal Tech, Baden-Baden 2018. ; Hildebrandt M., Smart Technologies and the End(s) of Law, Northampton 2016. ; Interpol Innovation Centre, Singapore, Innovation Report Artificial Intelligence, https://media.licdn.com/dms/document/C4E1FAQHbu EqCSHEUsQ/feedshare-document-pdf-analyzed/0?e=1549350000&v=beta&t=lpYHjU3SizFf82swBk3g33TLFqWGRy8EjbKyhLPsST0. ; Johnson D. R. and Post D., Law And Borders: the Rise of Law in Cyberspace, "Stanford Law Review"1996, vol. 48, no. 5. ; Kerikmäe T. (ed.) Regulating eTechnologies in the European Union. Normative Realities and Trends, Cham 2014. ; Krasuski A., Status sztucznego agenta. Podstawy zastosowania sztucznej inteligencji, Warsaw 2021. ; Kulesza J., Międzynarodowe prawo Internetu, Poznań 2010. ; Lai L. and Świerczyński M. (eds.), Prawo Sztucznej Inteligencji, Warsaw 2020. ; Leens R., Regulating New Technologies in Times of Change, (in:) L. Reins (ed.), Regulating New Technologies in Uncertain Times, Cham 2019. ; Lessig L., Code and Other Laws of Cyberspace, New York 1999. ; Lessig L., Code is Law: On Liberty in Cyberspace, "Harvard Magazine", https://harvardmagazine.com/2000/ 01/code-is-law-html. ; Liability for Artificial Intelligence and other emerging digital technologies: Report from the Expert Group on Liability and New Technologies – New Technologies Formation, https://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupMeetingDoc&docid=36608. ; M. Hildebrandt, Algorithmic Regulation and the Rule of Law, "Philosophical Transactions of the Royal Society A" 2018, vol. 376, issue 2128, https://royalsocietypublishing.org/doi/10.1098/ rsta.2017.0355. ; Magnusson Sjöberg C., Legal Automation, AI and Law Revisited, (in:) M. Corrales, M. Fenwick and Haapio H., Legal Tech, Smart Contracts and Blockchain, Singapore 2019. ; McCarthy J., Minsky M.L., Rochester N. and Shannon C.E., A Proposal for the Dartmouth Summer Research Project on Artificial Intelligence http://jmc.stanford.edu/articles/dartmouth/ dartmouth.pdf. ; Menthe D.C., Jurisdiction in Cyberspace: a Theory of International Spaces, "Michigan Telecommunications and Technology Law Review" 1998, no. 69. ; Minsky M., Perceptrons: An Introduction to Computational Geometry, Massachusetts 1969. ; Minsky M., The Emotion Machine. Commonsense Thinking, Artifi cial Intelligence, and the Future of the Human Mind, New York/London/Toronto/Sydney 2007. ; Nanda R., Siragusa G., Di Caro L., Boella G., Grossio L., Gerbaudo M. and Costamanga F., Unsupervised and Supervised Text Similarity Systems for Automated Identification of National Implementing Measures of European Directives, "Artificial Intelligence and Law" 2019, vol. 27. ; National Artificial Intelligence Strategy of the Czech Republic, https://www.mpo.cz/assets/en/guidepost/for-the-media/press releases/2019/5/NAIS_eng_web.pdf. ; Prabucki R., Szostek D. and Wyczik J., Prawo jako kod, (in:) D. Szostek (ed.), Legal tech. Czyli jak bezpiecznie korzystać z narzędzi informatycznych w organizacji, w tym w kancelarii oraz dziale prawnym, Warsaw 2021. ; Proposal For A Regulation Of The European Parliament And Of The Council Laying Down Harmonised Rules On Artificial Intelligence (Artificial Intelligence Act) And Amending Certain Union Legislative Acts Com/2021/206 Final, https://Eur-Lex.Europa.Eu/Legal-Content/EN/TXT/?Uri=CELEX:52021PC0206. ; Railas L., The Rise of the Lex Electronica and the International Sale of Goods, Helsinki 2004. ; Recommendation of Committee of Ministers No. 2102 (2017) about technological convergence, artificial intelligence and human rights (Doc. 14432). ; Recommendation of the Council on Artificial Intelligence, OECD, https://legalinstruments.oecd.org/en/instruments/OECD-LEGAL-0449. ; Recommendations on regulation, innovation and finance: Final Report to the European Commission, 01.12.2019, https://ec.europa.eu/info/sites/info/files/business_economy_euro/banking_and_finance/documents/191113-report-expert-group-regulatory-obstacles-financial-innovation_en.pdf. ; Report with recommendations to the Commission on a civil liability regime for artificial intelligence (2020/2014(INL)), https://www.europarl.europa.eu/doceo/document/A-9–2020-0178_EN.html. ; Responsibility and AI: Council of Europe study, 21.12.2019, https://rm.coe.int/ responsability-and-ai-en/168097d9c5. ; Schrebak S., Integrating Computer Science into Legal Discipline: Th e Rise of Legal Programming, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2496094. ; Szostek D. (ed.), Legal tech. Czyli jak bezpiecznie korzystać z narzędzi informatycznych w organizacji, w tym w kancelarii oraz dziale prawnym, Warsaw 2021. ; Szostek D., Blockchain and Law, Baden-Baden 2019. ; Szostek D., Czynność prawna a środki komunikacji elektronicznej, Krakow 2004. ; Szostek D., Sztuczna inteligencja a kody. Czy rozwiązaniem dla uregulowania sztucznej inteligencji jest smart contract i blockchain? (in:) L. Lai and M. Świerczyński (eds.), Prawo Sztucznej Inteligencji, Warsaw 2020. ; Szpringer W., Blockchain jako innowacja systemowa. Od Internetu informacji do Internetu wartości, Warsaw 2018. ; Świerczyński M. and Lai L., Prawo Sztucznej Inteligencji, Warsaw 2020. ; Tegmark M., Życie 3.0. Człowiek w Erze sztucznej Inteligencji, Warsaw 2019. ; The European Commission's high-level expert group on artificial intelligence, A definition of AI: Main capabilities and scientific disciplines. Definition developed for the purpose of the deliverables of the High-Level Expert Group on AI, Brussels, 18.12.2018, https://ec.europa.eu/digital-single-market/en/news/defi nition-artifi cial-intelligence-main-capabilities-and-scientific-disciplines. ; The High-Level Expert Group on Artificial Intelligence European Commission Directorate-General for Communications Networks Technology, 20.09.2018. ; Trudel P., La lex electronica, (in:) C.A. Morand (ed.), Le droit saisi par la mondialisation, Brussels 2001. ; Turing A., Computing Machinery and Intelligence, "Mind" 1950, vol. 49, no. 236. ; Turner J., Robot Rules. Regulating Artificial Intelligence, Cham 2019. ; Wendehorst C.H., Safety and Liability Related Aspect of Software, 17.06.2021, https://digital-strategy.ec.europa.eu/en/library/study-safety-and-liability-related-aspects-software. ; Werbach K., The Blockchain and the New Architecture of Trust, London 2018. ; White Paper On Artificial Intelligence. A European approach to excellence and trust, COM(2020) 65 final, European Commission, https://ec.europa.eu/info/sites/info/files/commission-white-paper-artificial-intelligence-feb2020_en.pdf. ; Wiebe A., Die elektronische Willenserklarung, Tubingen 2002. ; Wood G., Ethereum: A Secure Decentralized Generalized Transaction Ledger (EIP-150 revision), http://gavwood.com/Paper.pdf. ; Wright N.D. (ed.), Artificial Intelligence, China, Russia, and the Global Order, Maxwell 2019. ; Yao M., Jia M. and Zhou A., Applied Artificial Intelligence. A Handbook for Business Leaders, Middletown 2018. ; Zalewski T., Definicja sztucznej inteligencji, (in:) L. Lai and M. Swierczyński (eds.), Prawo Sztucznej Inteligencji, Warsaw 2020. ; 26
ABSTRAK Penelitian ini bertujuan untuk mengetahui dan menganalisis pengaruh Analisis Pengaruh Harga, Kualitas produk dan Viral Marketing terhadap Keputusan Pembelian pada Online Shop. Data penelitian diperoleh dengan menyebarkan kuesioner yang menggunakan skala likert, dengan menggunakan sampel 100 orang responden. Responden dalam penelitian ini adalah konsumen yang melakukan pembelian oblong itam di online shop yang berdomisili di kota Pontianak. Penelitian ini menggunakan metode purposive sampling dan menggunakan teknik analisis regresi berganda.Hasil penelitian ini menunjukkan bahwa harga, kualitas produk dan juga viral marketing bernilai positif dan berpengaruh signifikan terhadap keputusan pembelian.Kata Kunci: Harga, Kualitas Produk, Viral Marketing, Keputusan Pembelian Online Shop, instagram DAFTAR PUSTAKAAkbar, Mada Faisal, 2017. Pengaruh Kualitas Produk dan Harga pada Keputusan Pembelian di Toko Online Mitraindo Tangerang Selatan. Tangerang: Jurnal Pemikiran Ilmiah dan Pendidikan Administrasi Perkantoran.Ali, Hasan. 2013. Marketing Dan Kasus-Kasus Pilihan. Yogyakarta. Caps (Center For Academic Publishing Service). Yogyakarta.Allysa, Nindia. 2018. Pengaruh Kualitas Produk terhadap Keputusan Pembelian pada Ozon Parfum Fragrance. Bandung: Fakultas Ekonomi dan Bisnis Universitas Islam Bandung.Arianty, Nel. 2015. Pengaruh Promosi Terhadap Keputusan Pelanggan Menggunakan Kartu Mentari Pada Pt. Indosat Tbk. Medan. Medan: Fakultas Ekonomi Universitas Muhammadiyah Sumatera Utara.Arifin, A. 2003. Komunikasi Poitik: Paradigma-Teori-Aplikasi-Strategi Dan Komunikasi Politik Indonesia. Pt. Balai Pustaka, Jakarta.Arifin. 2011. Metode Penelitian Kualitatif, Kuantitatif, dan R & D. Bandung: Alfabeta.Armstrong & Kotler. 2004. Prinsip-prinsip Pemasaran (Edisi ke 12, Jilid 1). Jakarta: Erlangga.Asriani, Demizsa. 2017. Pengaruh viral marketing terhadap keputusan pembelian di Ngorea Bistro Bandung. Bandung: Fakultas Ekonomi dan Bisnis Universitas Islam Bandung.Ali, Hasan. 2013. Marketing Dan Kasus-Kasus Pilihan. Yogyakarta. Caps (Center For Academic Publishing Service). Yogyakarta.Bayu, Yulianto Dan Khuzaini, 2013. Pengaruh Produk, Harga, Promosi, Dan Layanan Terhadap Keputusan Konsumen Membeli Sepeda Motor Kawasaki, Jurnal Ilmu Dan Riset Manajemen, Volume1, Nomor 1 Januari 2013 Hal 25-46, Sekolah Tinggi Ilmu Ekonomi Indonesia (Stiesia) Surabaya. Doni, Hariadi. 2013. Pengaruh Harga, Produk, Dan Promosi, Dan Distribusi Terhadap Keputusan Pembelian Konsumen Pada Produk Projector Microvision, Jurnal Ilmu Dan Risetmanajemen, Vol 1 Nomor 1, Januari 2013, Hal 67-87, Sekolah Tinggi Ilmu Ekonomi Indonesia (STIESIA) Surabaya.Hidayati, Nur Laili. 2018. Pengaruh Viral Marketing, Online Consumer Reviews dan Harga Terhadap Keputusan Pembelian Shopee Di Surabaya. Surabaya: Fakultas Ekonomi Universitas Negeri Surabaya.Muliasari, Dewi. 2020. The Effect Of Product Price and Product Quality on Purchasing Decisions for Samsung Brand Handphones Among Stie Aas Surakarta Students. Surakarta: International Journal of Economics, Business and Accounting Research (IJEBAR).Nurgiyanto, Singgih (2014) "Pengaruh Strategi Promosi Melalui Social Media Terhadap Keputusan Pembelian Garskin Yang Dimediasi Word Of Mouth Marketing" Jurnal Universitas Negeri Yogyakarta, Vol 4, No.2 Nanda, Nurul Nadzfah. 2019. The Influence Of E-Commerce, Product Prices And Product Design On Purchasing Decisions In Souvenir Shop Tauko Medan. Medan: Budapest International Research and Critics Institute-Journal (BIRCI-Journal).Nurdianto, Rochmat (2013) "Pengaruh Meda Promosi Terhadap Preferensi Belanja Online Produk Eektronik" Jurnal Maajmen Dan Bisnis, No.1 (Sep). Http://Ejournal.Umpwr.Ac.Id/Index.Phpsegmen/Article/View/375, Diakses 4 Juni 2018 Irawan, Farid Wijaya, M.N. Sudjono, 2001, Pemasaran Prinsip Dan Kasus, Bpfe, Yogyakarta.Setidai, Nugroho J. (2003). Perilaku Konsumen Jakarta: Prenata MediaHasan, Ali. (2010). Marketing Dari Mulut Ke Mulut: Word Of Mouth Marketing. Jakarta: Media Pressindo (Medpress)Ho,J.Y.C& Dempsey, M. 2010. Viral Marketing: Motivation To Forward Online Content. Journal Of Business ResearchKawiji & Setyowati, Nuning. 2013. Pengembangan Usaha Kerajinan Rotan (Pendekatan Action Research) Studi Kasus Di UKM Asri Rotan Desa Trangsan Kecamatan Gatak, Kabupaten Sukoharjo. Jurnal Inovasi dan kewirausahaan 2(1): 9-18.Kotler, Philip 2012. Manajemen Pemasaran: Analisis Perencanaan, Implementasi Dan Kontrol. Pt Prenhalindo. Jakarta.Kotler Dan Amstrong (20013). Manajemen Pemasaran. Jilid I. Edisi Ke 13. Jakarta: ErlanggaTjiptono, Fandy. 2008. Strategi Pemasaran, Edisi 3,Andi: YogyakartaStanton, Wiliam J. 1998. Prinsip Pemasaran Edisi Ketujuh Jilid 1 . Jakarta: Erlangga.Kotler, Philip. 1996. Manajemen Pemasaran: Analisis Perencanaan Implementasi dan Pengendalian. Jilid 2. Jakarta: PT. Prenhallindo.Kotler, philip 2003. Manajemen pemasaran: Edisi kesebelas Jakarta . indeks kelompok gramedia.Kotler, Philip dan Kevin Lane Keller. 2009. Manajemen PemasaranEdisi 13 Jilid 1. Jakarta: Erlangga.Kotler, Philip and Kevin Lane Keller 2016. Marketing Managemet. Edisi 15 Global Edition. Pearson.Kotler, Philip dan Gary Amstrong. 2018. Principles of Marketing. Edisi 15 Global Edition. Pearson.Muliajaya, Made. 2019.Pengaruh Viral Marketing dan Harga Terhadap Keputusan Pembelian Melalui Media Sosial Instagram pada Mahasiswa Program Studi Pendidikan Ekonomi Universitas Pendidikan Ganesha. Medan: Universitas Pendidikan Ganesha.Rares, Angelina. 2015. Pengaruh Harga, Promosi, Lokasi, Citra Merek dan Kualitas Produk Terhadap Keputusan Pembelian Konsumen di Toko Bengkel Gaoel Manado Town Square.Manado :Fakultas Ekonomi dan Bisnis, Jurusan Manajemen Universitas Sam Ratulangi.Sampitri, Debby E. (2016) "Instagram Sebagai Media Promosi Online Shop" JurnalManajemendanbisnis."Http://Etd.Repository.Ugm.Ac.Id/Index.Php?Act=View&Buku_Id=103855&Mod=Penelitian_Detail&Sub=Penelitiandetail&Typ=Html, Diakses 4 Juni 2020.Siregar, Syofian. 2013. Metode Penelitian Kuantitatif. Jakarta: PT Fajar Interpratama Mandiri.Sopiah. Syihabudhin. 2008. Manajemen Bisnis Ritel. Yogyakarta: Andi Ofsset.Sandala, Dicki. 2019. Pengaruh Viral Marketing, Food Quality dan Brand Trust Terhadap Keputusan Pembelian Produk Mom Milk Manado. Manado: Fakultas Ekonomi dan Bisnis, Jurusan Manajemen Universitas Sam Ratulangi.Tjiptono, Fandy. (2002). Strategi Pemasaran. Yogyakarta : Penerbit Andi.Djaslim, Saladin (2004). Manajemen Pemasaran Edisi Ke-3, Bandung: Linda Karya.Wati, Suka. 2020. The Effect of Trust, Price, and Product Quality on Internet Purchase Decision in Makassar. Makassar :Phinisi Integration Review.Yulizar,Ahmad dan Dra. Apriatni EP.2015. PENGARUH HARGA DANPROMOSI TERHADAP KEPUTUSAN PEMBELIAN LAPTOP MEREK ACER(Studi Kasus pada Mahasiswa FISIP UNDIP Semarang). Semarang: Fakultas Ilmu Sosial dan Politik Universitas Diponegoro.Http://Hafizilmip.Blogspot.Com/2016/11/Makalah-Pengaruhpromosi-Melalui-Media.Html, Diakses 4 Juni 2020. Http://Www.Merdeka.Com/Teknologi/Read/Ini-5-Perkembangan-Teknologi-Yang-Akan-Terjadi-Tahun-2016/Indivation-Of-Things.Html, Diakses 3 Juni 2020 Http://Www.Wikipedia.Orgwiki/Read/Instagram, Diakses 3 Juni 2020 Http://Www.Wikipedia.Orgwiki/Read/Daftar_Negara_Menurut_Jumlah_Pengguna_Internet, Diakses 3 Juni 2020
Publisher's version (útgefin grein) ; Background In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990-2010 time period, with the greatest annualised rate of decline occurring in the 0-9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10-24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10-24 years were also in the top ten in the 25-49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50-74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and development investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd. ; Research reported in this publication was supported by the Bill & Melinda Gates Foundation; the University of Melbourne; Queensland Department of Health, Australia; the National Health and Medical Research Council, Australia; Public Health England; the Norwegian Institute of Public Health; St Jude Children's Research Hospital; the Cardiovascular Medical Research and Education Fund; the National Institute on Ageing of the National Institutes of Health (award P30AG047845); and the National Institute of Mental Health of the National Institutes of Health (award R01MH110163). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The authors alone are responsible for the views expressed in this Article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated, the National Health Service (NHS), the National Institute for Health Research (NIHR), the UK Department of Health and Social Care, or Public Health England; the United States Agency for International Development (USAID), the US Government, or MEASURE Evaluation; or the European Centre for Disease Prevention and Control (ECDC). This research used data from the Chile National Health Survey 2003, 2009-10, and 2016-17. The authors are grateful to the Ministry of Health, the survey copyright owner, for allowing them to have the database. All results of the study are those of the authors and in no way committed to the Ministry. The Costa Rican Longevity and Healthy Aging Study project is a longitudinal study by the University of Costa Rica's Centro Centroamericano de Poblacion and Instituto de Investigaciones en Salud, in collaboration with the University of California at Berkeley. The original pre-1945 cohort was funded by the Wellcome Trust (grant 072406), and the 1945-55 Retirement Cohort was funded by the US National Institute on Aging (grant R01AG031716). The principal investigators are Luis Rosero-Bixby and William H Dow and co-principal investigators are Xinia Fernandez and Gilbert Brenes. The accuracy of the authors' statistical analysis and the findings they report are not the responsibility of ECDC. ECDC is not responsible for conclusions or opinions drawn from the data provided. ECDC is not responsible for the correctness of the data and for data management, data merging and data collation after provision of the data. ECDC shall not be held liable for improper or incorrect use of the data. The Health Behaviour in School-Aged Children (HBSC) study is an international study carried out in collaboration with WHO/EURO. The international coordinator of the 1997-98, 2001-02, 2005-06, and 2009-10 surveys was Candace Currie and the databank manager for the 1997-98 survey was Bente Wold, whereas for the following surveys Oddrun Samdal was the databank manager. A list of principal investigators in each country can be found on the HBSC website. Data used in this paper come from the 2009-10 Ghana Socioeconomic Panel Study Survey, which is a nationally representative survey of more than 5000 households in Ghana. The survey is a joint effort undertaken by the Institute of Statistical, Social and Economic Research (ISSER) at the University of Ghana and the Economic Growth Centre (EGC) at Yale University. It was funded by EGC. ISSER and the EGC are not responsible for the estimations reported by the analysts. The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with license number SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law, 2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. Data for this research was provided by MEASURE Evaluation, funded by USAID. The authors thank the Russia Longitudinal Monitoring Survey, conducted by the National Research University Higher School of Economics and ZAO Demoscope together with Carolina Population Center, University of North Carolina at Chapel Hill and the Institute of Sociology, Russia Academy of Sciences for making data available. This paper uses data from the Bhutan 2014 STEPS survey, implemented by the Ministry of Health with the support of WHO; the Kuwait 2006 and 2014 STEPS surveys, implemented by the Ministry of Health with the support of WHO; the Libya 2009 STEPS survey, implemented by the Secretariat of Health and Environment with the support of WHO; the Malawi 2009 STEPS survey, implemented by Ministry of Health with the support of WHO; and the Moldova 2013 STEPS survey, implemented by the Ministry of Health, the National Bureau of Statistics, and the National Center of Public Health with the support of WHO. This paper uses data from Survey of Health, Ageing and Retirement in Europe (SHARE) Waves 1 (DOI:10.6103/SHARE. w1.700), 2 (10.6103/SHARE.w2.700), 3 (10.6103/SHARE.w3.700), 4 (10.6103/SHARE.w4.700), 5 (10.6103/SHARE.w5.700), 6 (10.6103/SHARE.w6.700), and 7 (10.6103/SHARE.w7.700); see Borsch-Supan and colleagues (2013) for methodological details. The SHARE data collection has been funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812), FP7 (SHARE-PREP: GA N degrees 211909, SHARE-LEAP: GA N degrees 227822, SHARE M4: GA N degrees 261982) and Horizon 2020 (SHARE-DEV3: GA N degrees 676536, SERISS: GA N degrees 654221) and by DG Employment, Social Affairs & Inclusion. Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the US National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C), and from various national funding sources is gratefully acknowledged. This study has been realised using the data collected by the Swiss Household Panel, which is based at the Swiss Centre of Expertise in the Social Sciences. The project is financed by the Swiss National Science Foundation. The United States Aging, Demographics, and Memory Study is a supplement to the Health and Retirement Study (HRS), which is sponsored by the National Institute of Aging (grant number NIA U01AG009740). It was conducted jointly by Duke University and the University of Michigan. The HRS is sponsored by the National Institute on Aging (grant number NIA U01AG009740) and is conducted by the University of Michigan. This paper uses data from Add Health, a program project designed by J Richard Udry, Peter S Bearman, and Kathleen Mullan Harris, and funded by a grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due to Ronald R Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website. No direct support was received from grant P01-HD31921 for this analysis. The data reported here have been supplied by the United States Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the US Government. Collection of data for the Mozambique National Survey on the Causes of Death 2007-08 was made possible by USAID under the terms of cooperative agreement GPO-A-00-08-000_D3-00. This manuscript is based on data collected and shared by the International Vaccine Institute (IVI) from an original study IVI conducted. L G Abreu acknowledges support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil; finance code 001) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, a Brazilian funding agency). I N Ackerman was supported by a Victorian Health and Medical Research Fellowship awarded by the Victorian Government. O O Adetokunboh acknowledges the South African Department of Science and Innovation and the National Research Foundation. A Agrawal acknowledges the Wellcome Trust DBT India Alliance Senior Fellowship. S M Aljunid acknowledges the Department of Health Policy and Management, Faculty of Public Health, Kuwait University and International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia for the approval and support to participate in this research project. M Ausloos, C Herteliu, and A Pana acknowledge partial support by a grant of the Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0084. A Badawi is supported by the Public Health Agency of Canada. D A Bennett was supported by the NIHR Oxford Biomedical Research Centre. R Bourne acknowledges the Brien Holden Vision Institute, University of Heidelberg, Sightsavers, Fred Hollows Foundation, and Thea Foundation. G B Britton and I Moreno Velasquez were supported by the Sistema Nacional de Investigacion, SNI-SENACYT, Panama. R Buchbinder was supported by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. J J Carrero was supported by the Swedish Research Council (2019-01059). F Carvalho acknowledges UID/MULTI/04378/2019 and UID/QUI/50006/2019 support with funding from FCT/MCTES through national funds. A R Chang was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant K23 DK106515. V M Costa acknowledges the grant SFRH/BHD/110001/2015, received by Portuguese national funds through Fundacao para a Ciencia e Tecnologia, IP, under the Norma Transitaria DL57/2016/CP1334/CT0006. A Douiri acknowledges support and funding from the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust and the Royal College of Physicians, and support from the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. B B Duncan acknowledges grants from the Foundation for the Support of Research of the State of Rio Grande do Sul (IATS and PrInt) and the Brazilian Ministry of Health. H E Erskine is the recipient of an Australian NHMRC Early Career Fellowship grant (APP1137969). A J Ferrari was supported by a NHMRC Early Career Fellowship grant (APP1121516). H E Erskine and A J Ferrari are employed by and A M Mantilla-Herrera and D F Santomauro affiliated with the Queensland Centre for Mental Health Research, which receives core funding from the Queensland Department of Health. M L Ferreira holds an NHMRC Research Fellowship. C Flohr was supported by the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust. M Freitas acknowledges financial support from the EU (European Regional Development Fund [FEDER] funds through COMPETE POCI-01-0145-FEDER-029248) and National Funds (Fundacao para a Ciencia e Tecnologia) through project PTDC/NAN-MAT/29248/2017. A L S Guimaraes acknowledges support from CNPq. C Herteliu was partially supported by a grant co-funded by FEDER through Operational Competitiveness Program (project ID P_40_382). P Hoogar acknowledges Centre for Bio Cultural Studies, Directorate of Research, Manipal Academy of Higher Education and Centre for Holistic Development and Research, Kalaghatagi. F N Hugo acknowledges the Visiting Professorship, PRINT Program, CAPES Foundation, Brazil. B-F Hwang was supported by China Medical University (CMU107-Z-04), Taichung, Taiwan. S M S Islam was funded by a National Heart Foundation Senior Research Fellowship and supported by Deakin University. R Q Ivers was supported by a research fellowship from the National Health and Medical Research Council of Australia. M Jakovljevic acknowledges the Serbian part of this GBD-related contribution was co-funded through Grant OI175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia. P Jeemon was supported by a Clinical and Public Health intermediate fellowship (grant number IA/CPHI/14/1/501497) from the Wellcome Trust-Department of Biotechnology, India Alliance (2015-20). O John is a recipient of UIPA scholarship from University of New South Wales, Sydney. S V Katikireddi acknowledges funding from a NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_12017/13, MC_UU_12017/15), and the Scottish Government Chief Scientist Office (SPHSU13, SPHSU15). C Kieling is a CNPq researcher and a UK Academy of Medical Sciences Newton Advanced Fellow. Y J Kim was supported by Research Management Office, Xiamen University Malaysia (XMUMRF/2018-C2/ITCM/00010). K Krishan is supported by UGC Centre of Advanced Study awarded to the Department of Anthropology, Panjab University, Chandigarh, India. M Kumar was supported by K43 TW 010716 FIC/NIMH. B Lacey acknowledges support from the NIHR Oxford Biomedical Research Centre and the BHF Centre of Research Excellence, Oxford. J V Lazarus was supported by a Spanish Ministry of Science, Innovation and Universities Miguel Servet grant (Instituto de Salud Carlos III [ISCIII]/ESF, the EU [CP18/00074]). K J Looker thanks the NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol, in partnership with Public Health England, for research support. S Lorkowski was funded by the German Federal Ministry of Education and Research (nutriCARD, grant agreement number 01EA1808A). R A Lyons is supported by Health Data Research UK (HDR-9006), which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, NIHR (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation, and Wellcome Trust. J J McGrath is supported by the Danish National Research Foundation (Niels Bohr Professorship), and the Queensland Health Department (via West Moreton HHS). P T N Memiah acknowledges support from CODESRIA. U O Mueller gratefully acknowledges funding by the German National Cohort Study BMBF grant number 01ER1801D. S Nomura acknowledges the Ministry of Education, Culture, Sports, Science, and Technology of Japan (18K10082). A Ortiz was supported by ISCIII PI19/00815, DTS18/00032, ISCIII-RETIC REDinREN RD016/0009 Fondos FEDER, FRIAT, Comunidad de Madrid B2017/BMD-3686 CIFRA2-CM. These funding sources had no role in the writing of the manuscript or the decision to submit it for publication. S B Patten was supported by the Cuthbertson & Fischer Chair in Pediatric Mental Health at the University of Calgary. G C Patton was supported by an aNHMRC Senior Principal Research Fellowship. M R Phillips was supported in part by the National Natural Science Foundation of China (NSFC, number 81371502 and 81761128031). A Raggi, D Sattin, and S Schiavolin were supported by grants from the Italian Ministry of Health (Ricerca Corrente, Fondazione Istituto Neurologico C Besta, Linea 4-Outcome Research: dagli Indicatori alle Raccomandazioni Cliniche). P Rathi and B Unnikrishnan acknowledge Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal. A L P Ribeiro was supported by Brazilian National Research Council, CNPq, and the Minas Gerais State Research Agency, FAPEMIG. D C Ribeiro was supported by The Sir Charles Hercus Health Research Fellowship (#18/111) Health Research Council of New Zealand. D Ribeiro acknowledges financial support from the EU (FEDER funds through the Operational Competitiveness Program; POCI-01-0145-FEDER-029253). P S Sachdev acknowledges funding from the NHMRC of Australia Program Grant. A M Samy was supported by a fellowship from the Egyptian Fulbright Mission Program. M M Santric-Milicevic acknowledges the Ministry of Education, Science and Technological Development of the Republic of Serbia (contract number 175087). R Sarmiento-Suarez received institutional support from Applied and Environmental Sciences University (Bogota, Colombia) and ISCIII (Madrid, Spain). A E Schutte received support from the South African National Research Foundation SARChI Initiative (GUN 86895) and Medical Research Council. S T S Skou is currently funded by a grant from Region Zealand (Exercise First) and a grant from the European Research Council under the EU's Horizon 2020 research and innovation program (grant agreement number 801790). J B Soriano is funded by Centro de Investigacion en Red de Enfermedades Respiratorias, ISCIII. R Tabares-Seisdedos was supported in part by the national grant PI17/00719 from ISCIII-FEDER. N Taveira was partially supported by the European & Developing Countries Clinical Trials Partnership, the EU (LIFE project, reference RIA2016MC-1615). S Tyrovolas was supported by the Foundation for Education and European Culture, the Sara Borrell postdoctoral programme (reference number CD15/00019 from ISCIII-FEDER). S B Zaman received a scholarship from the Australian Government research training programme in support of his academic career. ; "Peer Reviewed"
Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97.1 (95% UI 95.8-98.1) in Iceland, followed by 96.6 (94.9-97.9) in Norway and 96.1 (94.5-97.3) in the Netherlands, to values as low as 18.6 (13.1-24.4) in the Central African Republic, 19.0 (14.3-23.7) in Somalia, and 23.4 (20.2-26.8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91.5 (89.1-936) in Beijing to 48.0 (43.4-53.2) in Tibet (a 43.5-point difference), while India saw a 30.8-point disparity, from 64.8 (59.6-68.8) in Goa to 34.0 (30.3-38.1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4.8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20.9-point to 17.0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17.2-point to 20.4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle-SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view and subsequent provision of quality health care for all populations. ; Bill & Melinda Gates Foundation. Barbora de Courten is supported by a National Heart Foundation Future Leader Fellowship (100864). Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII —General Branch Evaluation and Promotion of Health Research—and the European Regional Development Fund (ERDF-FEDER). Alberto Ortiz was supported by Spanish Government (Instituto de Salud Carlos III RETIC REDINREN RD16/0019 FEDER funds). Ashish Awasthi acknowledges funding support from Department of Science and Technology, Government of India through INSPIRE Faculty scheme Boris Bikbov has received funding from the European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie grant agreement No. 703226. Boris Bikbov acknowledges that work related to this paper has been done on the behalf of the GBD Genitourinary Disease Expert Group. Panniyammakal Jeemon acknowledges support from the clinical and public health intermediate fellowship from the Wellcome Trust and Department of Biotechnology, India Alliance (2015–20). Job F M van Boven was supported by the Department of Clinical Pharmacy & Pharmacology of the University Medical Center Groningen, University of Groningen, Netherlands. Olanrewaju Oladimeji is an African Research Fellow hosted by Human Sciences Research Council (HSRC), South Africa and he also has honorary affiliations with Walter Sisulu University (WSU), Eastern Cape, South Africa and School of Public Health, University of Namibia (UNAM), Namibia. He is indeed grateful for support from HSRC, WSU and UNAM. EUI is supported in part by the South African National Research Foundation (NRF UID: 86003). Ulrich Mueller acknowledges funding by the German National Cohort Study grant No 01ER1511/D, Gabrielle B Britton is supported by Secretaría Nacional de Ciencia, Tecnología e Innovación and Sistema Nacional de Investigación de Panamá. Giuseppe Remuzzi acknowledges that the work related to this paper has been done on behalf of the GBD Genitourinary Disease Expert Group. Behzad Heibati would like to acknowledge Air pollution Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. Syed Aljunid acknowledges the National University of Malaysia for providing the approval to participate in this GBD Project. Azeem Majeed and Imperial College London are grateful for support from the Northwest London National Insititute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care. Tambe Ayuk acknowledges the Institute of Medical Research and Medicinal Plant Studies for office space provided. José das Neves was supported in his contribution to this work by a Fellowship from Fundação para a Ciência e a Tecnologia, Portugal (SFRH/BPD/92934/2013). João Fernandes gratefully acknowledges funding from FCT–Fundação para a Ciência e a Tecnologia (grant number UID/Multi/50016/2013). Jan-Walter De Neve was supported by the Alexander von Humboldt Foundation. Kebede Deribe is funded by a Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (201900). Kazem Rahimi was supported by grants from the Oxford Martin School, the NIHR Oxford BRC and the RCUK Global Challenges Research Fund. Laith J Abu-Raddad acknowledges the support of Qatar National Research Fund (NPRP 9-040-3-008) who provided the main funding for generating the data provided to the GBD-IHME effort. Liesl Zuhlke is funded by the national research foundation of South Africa and the Medical Research Council of South Africa. Monica Cortinovis acknowledges that work related to this paper has been done on the behalf of the GBD Genitourinary Disease Expert Group. Chuanhua Yu acknowleges support from the National Natural Science Foundation of China (grant number 81773552 and grant number 81273179) Norberto Perico acknowledges that work related to this paper has been done on behalf of the GBD Genitourinary Disease Expert Group. Charles Shey Wiysonge's work is supported by the South African Medical Research Council and the National Research Foundation of South Africa (grant numbers 106035 and 108571). John J McGrath is supported by grant APP1056929 from the John Cade Fellowship from the National Health and Medical Research Council and the Danish National Research Foundation (Niels Bohr Professorship). Quique Bassat is an ICREA (Catalan Institution for Research and Advanced Studies) research professor at ISGlobal. Richard G White is funded by the UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement that is also part of the EDCTP2 programme supported by the European Union (MR/P002404/1), the Bill & Melinda Gates Foundation (TB Modelling and Analysis Consortium: OPP1084276/OPP1135288, CORTIS: OPP1137034/OPP1151915, Vaccines: OPP1160830), and UNITAID (4214-LSHTM-Sept15; PO 8477-0-600). Rafael Tabarés-Seisdedos was supported in part by grant number PROMETEOII/2015/021 from Generalitat Valenciana and the national grant PI17/00719 from ISCIII-FEDER. Mihajlo Jakovljevic acknowleges contribution from the Serbian Ministry of Education Science and Technological Development of the Republic of Serbia (grant OI 175 014). Shariful Islam is funded by a Senior Fellowship from Institute for Physical Activity and Nutrition, Deakin University and received career transition grants from High Blood Pressure Research Council of Australia. Sonia Saxena is funded by various grants from the NIHR. Stefanos Tyrovolas was supported by the Foundation for Education and European Culture, the Sara Borrell postdoctoral program (reference number CD15/00019 from the Instituto de Salud Carlos III (ISCIII–Spain) and the Fondos Europeo de Desarrollo Regional. Stefanos was awarded with a 6 months visiting fellowship funding at IHME from M-AES (reference no. MV16/00035 from the Instituto de Salud Carlos III). S Vittal Katikreddi was funded by a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the MRC (MC_UU_12017/13 & MC_ UU_12017/15) and the Scottish Government Chief Scientist Office (SPHSU13 & SPHSU15). Traolach S Brugha has received funding from NHS Digital UK to collect data used in this study. The work of Hamid Badali was financially supported by Mazandaran University of Medical Sciences, Sari, Iran. The work of Stefan Lorkowski is funded by the German Federal Ministry of Education and Research (nutriCARD, Grant agreement number 01EA1411A). Mariam Molokhia's research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. We also thank the countless individuals who have contributed to GBD 2016 in various capacities. ; Peer reviewed
The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. Data for this research was provided by MEASURE Evaluation, funded by the United States Agency for International Development (USAID). Views expressed do not necessarily reflect those of USAID, the US Government, or MEASURE Evaluation. The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with licence no. SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law-2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. ; Background Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent with the estimates of the numbers of deaths in the GBD. The present iteration of the GBD, GBD 2017, improves on previous assessments and provides timely estimates of the mortality experience of populations globally. Methods The GBD uses all available data to produce estimates of mortality rates between 1950 and 2017 for 23 age groups, both sexes, and 918 locations, including 195 countries and territories and subnational locations for 16 countries. Data used include vital registration systems, sample registration systems, household surveys (complete birth histories, summary birth histories, sibling histories), censuses (summary birth histories, household deaths), and Demographic Surveillance Sites. In total, this analysis used 8259 data sources. Estimates of the probability of death between birth and the age of 5 years and between ages 15 and 60 years are generated and then input into a model life table system to produce complete life tables for all locations and years. Fatal discontinuities and mortality due to HIV/AIDS are analysed separately and then incorporated into the estimation. We analyse the relationship between age-specific mortality and development status using the Socio-demographic Index, a composite measure based on fertility under the age of 25 years, education, and income. There are four main methodological improvements in GBD 2017 compared with GBD 2016: 622 additional data sources have been incorporated; new estimates of population, generated by the GBD study, are used; statistical methods used in different components of the analysis have been further standardised and improved; and the analysis has been extended backwards in time by two decades to start in 1950. Findings Globally, 18·7% (95% uncertainty interval 18·4–19·0) of deaths were registered in 1950 and that proportion has been steadily increasing since, with 58·8% (58·2–59·3) of all deaths being registered in 2015. At the global level, between 1950 and 2017, life expectancy increased from 48·1 years (46·5–49·6) to 70·5 years (70·1–70·8) for men and from 52·9 years (51·7–54·0) to 75·6 years (75·3–75·9) for women. Despite this overall progress, there remains substantial variation in life expectancy at birth in 2017, which ranges from 49·1 years (46·5–51·7) for men in the Central African Republic to 87·6 years (86·9–88·1) among women in Singapore. The greatest progress across age groups was for children younger than 5 years; under-5 mortality dropped from 216·0 deaths (196·3–238·1) per 1000 livebirths in 1950 to 38·9 deaths (35·6–42·83) per 1000 livebirths in 2017, with huge reductions across countries. Nevertheless, there were still 5·4 million (5·2–5·6) deaths among children younger than 5 years in the world in 2017. Progress has been less pronounced and more variable for adults, especially for adult males, who had stagnant or increasing mortality rates in several countries. The gap between male and female life expectancy between 1950 and 2017, while relatively stable at the global level, shows distinctive patterns across super-regions and has consistently been the largest in central Europe, eastern Europe, and central Asia, and smallest in south Asia. Performance was also variable across countries and time in observed mortality rates compared with those expected on the basis of development. Interpretation This analysis of age-sex-specific mortality shows that there are remarkably complex patterns in population mortality across countries. The findings of this study highlight global successes, such as the large decline in under-5 mortality, which reflects significant local, national, and global commitment and investment over several decades. However, they also bring attention to mortality patterns that are a cause for concern, particularly among adult men and, to a lesser extent, women, whose mortality rates have stagnated in many countries over the time period of this study, and in some cases are increasing. ; Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the University of Melbourne, Public Health England, the Norwegian Institute of Public Health, St. Jude Children's Research Hospital, the National Institute on Aging of the National Institutes of Health (award P30AG047845), and the National Institute of Mental Health of the National Institutes of Health (award R01MH110163). ; Peer reviewed